Skip to main content
  • Conference proceedings
  • © 2005

New Mechanisms for Tissue-Selective Estrogen-Free Contraception

Part of the book series: Ernst Schering Foundation Symposium Proceedings (SCHERING FOUND, volume 52)

Buy it now

Buying options

eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (11 papers)

  1. Front Matter

    Pages I-XII
  2. Reproductive Tissue-Selective Actions of Progesterone Receptors

    • B. Mulac-Jericevic, O. M. Conneely
    Pages 19-37
  3. The Progesterone Receptor/Estradiol Receptor Association and the Progestin-Triggered S-Phase Entry

    • A. Migliaccio, G. Castoria, M. Di Domenico, C. Ballaré, M. Beato, F. Auricchio
    Pages 39-54
  4. Endometrial Morphology and Progestogens

    • H. O. D. Critchley
    Pages 55-88
  5. Effects of Progestogens on Endometrial Maturation in the Implantation Phase

    • K. Gemzell-Danielsson, M. Bygdeman
    Pages 119-138
  6. Gene Expression During the Implantation Window: Microarray Analysis of Human Endometrial Samples

    • A. Schmidt, P. Groth, B. Haendler, H. Hess-Stumpp, J. Krätzschmar, H. Seidel et al.
    Pages 139-157
  7. Human Endocervical Mucins

    • I. K. Gipson
    Pages 219-244
  8. Back Matter

    Pages 263-266

About this book

Combined oral contraceptives are the most convenient and accepted method of hormonal contraception. Nevertheless, the medical community and consumers constantly demand innovation, additional benefits during use and lower hormonal load despite the high safety profile of available products. At the Ernst Schering Research Foundation Workshop 52, new perspectives and mechanisms for tissue-selective, estrogen-free contraception were discussed. The aim of the workshop was to bring together experts in the field of molecular and pharmacodynamic action of progestins with clinicians and medical experts to discuss potential medical endpoints, physiological reactions and (bio)marker useful describing the tissue selectivity and the contraceptive action of new progestins in different target organs. A major factor for successful realization of these new concepts is a deeper understanding of local pharmacological responses to progestins in general and to new progestins in particular.

Editors and Affiliations

  • Instituto Chileno de Medicina Reproductive (ICMER), Santiago de Chile, Chile

    H. B. Croxatto

  • Strategic Business Unit, Gynecology and Andrology, Schering AG, Berlin, Germany

    R. Schürmann, I. Schellschmidt

  • CRBA, Gynecology and Andrology, Female Health Care, Schering AG, Berlin, Germany

    U. Fuhrmann

Bibliographic Information

Buy it now

Buying options

eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access